Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2014
09/23/2014CA2543199C Use of crth2 antagonist compounds in therapy
09/18/2014WO2014145600A1 Ach-0142684 sodium salt polymorphs, composition including the same, and method of manufacture thereof
09/18/2014WO2014145512A2 Potent small molecule inhibitors of autophagy, and methods of use thereof
09/18/2014WO2014144610A1 Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
09/18/2014WO2014144169A1 Carm1 inhibitors and uses thereof
09/18/2014WO2014143960A1 Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl) methanone compounds as cancer cell growth inhibitors
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014141175A1 Novel acrylamide derivatives as antimalarial agents
09/18/2014WO2014141153A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
09/18/2014WO2014141104A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
09/18/2014WO2014141065A1 Azetidine amide derivatives as orexin receptor antagonists
09/18/2014WO2014140310A1 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014WO2014140081A1 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140078A1 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140059A1 ARYL SULFAMIDE AND SULFAMATE DERIVATIVES AS RORc MODULATORS
09/18/2014WO2014139981A1 Dihydroquinoline-2-one derivatives for use as aldosterone synthase inhibitors
09/18/2014WO2014139325A1 Therapeutic compounds and compositions
09/18/2014WO2014139190A1 Nicotine compound, and preparation method and usage thereof
09/18/2014WO2014139150A1 Substituted pyridizinone derivatives as pde10 inhibitors
09/18/2014WO2014138812A1 Salts, co-crystals, and polymorphs of an anxiolytic compound
09/18/2014US20140275711 1-(Arylmethyl)-5,6,7,8-tetrahydroquinazolline-2,4-diones and Analogs and the Use Thereof
09/18/2014US20140275531 Substituted pyridine and pyrazine compounds as pde4 inhibitors
09/18/2014US20140275224 Cytosine deaminase modulators for enhancement of dna transfection
09/18/2014US20140275185 Novel S-Nitrosoglutathione Reductase Inhibitors
09/18/2014US20140275180 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
09/18/2014US20140275179 Gpr120 agonists for the treatment of type ii diabetes
09/18/2014US20140275178 Thiazole compounds, compositions and methods for treatment of degenerative diseases and disorders
09/18/2014US20140275175 Organic compounds
09/18/2014US20140275169 Combination Therapies for Enhancing Protein Degradation
09/18/2014US20140275159 Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275155 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275129 Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds
09/18/2014US20140275114 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275103 Compositions, formulations and methods for treating ocular diseases
09/18/2014US20140275086 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014US20140275083 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
09/18/2014US20140275080 N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
09/18/2014US20140275077 Uracil derivatives as axl and c-met kinase inhibitors
09/18/2014US20140275076 Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative
09/18/2014US20140275072 Morpholinylbenzotriazines for use in cancer therapy
09/18/2014US20140275058 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
09/18/2014US20140275050 2,5-disubstituted thiomorpholine orexin receptor antagonists
09/18/2014US20140275033 Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereof
09/18/2014US20140275032 ARYL SULFAMIDE AND SULFAMATE DERIVATIVES AS RORc MODULATORS
09/18/2014US20140275028 1,2,5-substituted benzimidazoles as flap modulators
09/18/2014US20140275024 Dna-pk inhibitors
09/18/2014US20140275012 Heteroaromatic compounds as btk inhibitors
09/18/2014US20140275011 Pyridine cdk9 kinase inhibitors
09/18/2014US20140275003 Biaryl amide compounds as kinase inhibitors
09/17/2014EP2778156A1 Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states
09/17/2014EP2778155A1 2-aminopyridine derivatives useful as kinase inhibitors
09/17/2014EP2776432A1 Aminopyrimidine kinase inhibitors
09/17/2014EP2776430A1 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
09/17/2014EP2776426A1 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
09/17/2014EP2776425A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
09/17/2014EP2776424A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an n-cyclic group as vanilloid receptor ligands
09/17/2014EP2776420A1 Pyrazine compounds useful as inhibitors of atr kinase
09/17/2014EP2776419A1 Pyrazine compounds useful as inhibitors of atr kinase
09/17/2014EP2776418A1 Inhibitors of phosphodiesterase type 10a
09/17/2014EP2776408A1 Anticancer benzopyrazines via the inhibition of fgfr kinases
09/17/2014EP2776405A1 2-thiopyrimidinones
09/16/2014US8835644 Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
09/16/2014US8835632 Methods to increase the photostability of dyes
09/16/2014US8835482 Substituted indazole and aza-indazole derivatives as gamma secretase modulators
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014US8835470 Mandelamide heterocyclic compounds
09/16/2014US8835469 Substituted benzamide derivatives as glucokinase (GK) activators
09/16/2014US8835461 Substituted 3-hydroxy-4-pyridone derivative
09/16/2014US8835440 Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
09/16/2014US8835438 Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone
09/16/2014US8835436 Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
09/16/2014US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
09/16/2014US8835430 2,4-pyrimidinediamine compounds and their uses
09/16/2014US8835428 Diacylglycerol acyltransferase inhibitors
09/16/2014US8835427 Fungicidal heterocyclic compounds
09/16/2014US8835419 Substituted anilines as CCR(4) antagonists
09/16/2014US8835418 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
09/16/2014US8835417 Crystalline hydrochloride salt of (1-(4-fluorophenyl)-1H-indol-5-yl)-(3-(4-(thiazole-2-carbonyl)piperazin-1-yl)azetidin-1-yl)methanone
09/16/2014CA2653666C Aryl-substituted heterocycles and their use
09/16/2014CA2623202C Hydrazide compound and pesticidal use of the same
09/12/2014WO2014138484A1 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
09/12/2014WO2014138199A1 Pyrimidine compounds for the treatment of hepatitis c
09/12/2014WO2014137301A1 Hydrazones and thiazolidinones derived from diflunisal
09/12/2014WO2014136860A1 Compound, luminescent material and organic luminescent element
09/12/2014WO2014136099A1 Process for ixabepilone, and intermediates thereof
09/12/2014WO2014135674A1 Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
09/12/2014WO2014135608A1 Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-heterocycle derivatives
09/12/2014WO2014135495A1 Antiviral compounds
09/12/2014WO2014135483A1 Antiviral compounds
09/12/2014WO2014135479A1 Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-oxadiazolone derivatives
09/12/2014WO2014135478A1 Fungicidal 3-{heterocyclyl[(heterocyclylmethoxy)imino]methyl}-oxadiazolone derivatives
09/12/2014WO2014135477A1 Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-oxadiazolone derivatives
09/12/2014WO2014135414A1 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
09/11/2014US20140256939 Process of preparing a quaternary ammonium salt using phosphate
09/11/2014US20140256771 Compounds that modulate intracellular calcium
09/11/2014US20140256756 Piperidinyl-substituted lactams as gpr119 modulators
09/11/2014US20140256753 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections
09/11/2014US20140256745 Compounds that modulate intracellular calcium
09/11/2014US20140256744 Polycyclic compounds as lysophosphatidic acid receptor antagonists
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 628